These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 20413257

  • 1. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
    Agle SC, McNally MM, Powell CS, Bogey WM, Parker FM, Stoner MC.
    Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
    [Abstract] [Full Text] [Related]

  • 2. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S, McWilliams-Dunnigan L, Blackham KL, Kirchner HL, Sundararajan S, Sunshine JL, Tarr RW, Selman WR, Landis DM, Suarez JI.
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [Abstract] [Full Text] [Related]

  • 3. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, Schwamm LH.
    J Stroke Cerebrovasc Dis; 2011 Sep; 20(2):124-30. PubMed ID: 20598579
    [Abstract] [Full Text] [Related]

  • 4. Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital.
    Wongwanit C, Hahtapornsawan S, Chinsakchai K, Sermsathanasawadi N, Hongku K, Ruangsetakit C, Mutirangura P.
    J Med Assoc Thai; 2013 Jun; 96(6):661-8. PubMed ID: 23951822
    [Abstract] [Full Text] [Related]

  • 5. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013 Jun; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 6. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
    Kellert L, Sykora M, Gumbinger C, Herrmann O, Ringleb PA.
    Cerebrovasc Dis; 2012 Jun; 33(2):135-40. PubMed ID: 22179586
    [Abstract] [Full Text] [Related]

  • 7. The effect of physiologic derangement in patients with stroke treated with thrombolysis.
    Idicula TT, Waje-Andreassen U, Brogger J, Naess H, Lundstadsveen MT, Thomassen L.
    J Stroke Cerebrovasc Dis; 2008 Jun; 17(3):141-6. PubMed ID: 18436155
    [Abstract] [Full Text] [Related]

  • 8. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2012 Jun; 34(2):140-6. PubMed ID: 22854333
    [Abstract] [Full Text] [Related]

  • 9. Hemorrhagic transformation during thrombolytic therapy and reperfusion: effects of age, blood pressure, and matrix metalloproteinases.
    Lyden PD.
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):532-8. PubMed ID: 23453556
    [Abstract] [Full Text] [Related]

  • 10. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients.
    Kim HS, Preece SR, Black JH, Pham LD, Streiff MB.
    J Vasc Surg; 2008 Feb; 47(2):388-94. PubMed ID: 18241762
    [Abstract] [Full Text] [Related]

  • 11. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D, Lorenzano S, Agnelli G, Guidetti D, Orlandi G, Semplicini A, Toso V, Caso V, Malferrari G, Fanucchi S, Bartolomei L, Prencipe M.
    Cerebrovasc Dis; 2008 Feb; 25(1-2):129-35. PubMed ID: 18073466
    [Abstract] [Full Text] [Related]

  • 12. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J, Frackowiak M, Zaro Weber O, Hahn M, Möller-Hartmann W, Rudolf J, Neveling M, Grond M, Schmulling S, Jacobs A, Heiss WD.
    Cerebrovasc Dis; 2007 Feb; 24(1):56-65. PubMed ID: 17519545
    [Abstract] [Full Text] [Related]

  • 13. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
    Lee K, Istl A, Dubois L, DeRose G, Forbes TL, Wiseman D, Mujoomdar A, Kribs S, Power AH.
    Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
    [Abstract] [Full Text] [Related]

  • 14. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N, Gits CC, Ehrenwald E, Cragg AH.
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [Abstract] [Full Text] [Related]

  • 15. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM, Schicchi R, Schirò M, Americo L, Bonnì G, Faraone N, Di Pasquale P, Castello A, Mauri F.
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [Abstract] [Full Text] [Related]

  • 16. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
    Mendioroz M, Fernández-Cadenas I, Alvarez-Sabín J, Rosell A, Quiroga D, Cuadrado E, Delgado P, Rubiera M, Ribó M, Molina C, Montaner J.
    Cerebrovasc Dis; 2009 Jan; 28(2):143-50. PubMed ID: 19546541
    [Abstract] [Full Text] [Related]

  • 17. Outcome of intravenous thrombolysis in stroke patients weighing over 100 kg.
    Sarikaya H, Arnold M, Engelter ST, Lyrer PA, Mattle HP, Michel P, Odier C, Weder B, Siebel P, Mueller F, Ballinari P, Georgiadis D, Baumgartner RW.
    Cerebrovasc Dis; 2011 Jan; 32(3):201-6. PubMed ID: 21822011
    [Abstract] [Full Text] [Related]

  • 18. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
    Bravo Y, Martí-Fàbregas J, Cocho D, Rodríguez-Yáñez M, Castellanos M, de la Ossa NP, Roquer J, Obach V, Maestre J, Martí-Vilalta JL.
    Cerebrovasc Dis; 2008 Jan; 26(2):126-33. PubMed ID: 18560215
    [Abstract] [Full Text] [Related]

  • 19. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.
    J Stroke Cerebrovasc Dis; 2008 Jan; 17(3):121-8. PubMed ID: 18436152
    [Abstract] [Full Text] [Related]

  • 20. [Simple and effective rt-PA thrombolysis design].
    Cejna M, Salomonowitz E, Wohlschlager H, Zwrtek K, Böck R.
    Rofo; 1998 Nov; 169(5):521-5. PubMed ID: 9849604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.